CClinicalTrials.gg
CompletedNCT03624465Updated Jan 1, 2025Results posted

Prospective Clinical Study of the Levita Magnetics Surgical System Used for Prostatectomy Surgery

An interventional study of Levita Magnetic Surgical System in Prostatectomy, sponsored by Levita Magnetics. Completed at 1 site in Chile. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-01-01.

Sponsored by Levita Magnetics · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years and older
Sex
Male
01

Study summary

The purpose of this study is to evaluate the safety and effectiveness of the Levita Magnetic Surgical System in patients undergoing prostatectomy surgery.

Read the detailed description

Prospective, multicenter, single-arm, open label study designed to assess the safety and effectiveness of the Levita Magnetic Surgical System in prostatectomy surgery.

02

Conditions studied

  • Prostatectomy
03

In context

Lead sponsor

Levita Magnetics is the lead sponsor of 10 studies on the registry; 1 is open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 3 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  • Subject is at least 18 years of age
  • Subject is scheduled to undergo elective prostatectomy surgery

Exclusion criteria

Exclusion Criteria:

  • Significant comorbidities
  • Subjects with pacemakers, defibrillators, or other electromedical implants
  • Subjects with ferromagnetic implants
  • Clinical history of impaired coagulation
  • Subject has an anatomical abnormality noted after initiation of index procedure that would prevent device use
  • Subject is not likely to comply with the follow-up evaluation schedule
  • Subject is participating in another clinical trial
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Levita Magnetic Surgical System

    Levita Magnetic Surgical System use of surgical tool

    Device: Levita Magnetic Surgical System

Interventions

  • DeviceLevita Magnetic Surgical System

    Device for use as a surgical tool.

06

What researchers measure

Primary outcomes

  1. Number of Tools Required to Retract the Prostate During Procedure

    Ability to adequately retract the prostate to achieve an effective exposure of the target tissue. Adequate retraction is achieved if it is not necessary to replace the Levita Magnetic Surgical System with another instrument to retract the prostate during the procedure.

    Time frame: During planned prostatectomy procudure

  2. Incidence of Device Related Adverse Events (Safety)

    All adverse events will be recorded and allocated as to relatedness to device, procedure or other.

    Time frame: Through 30 days post prostatectomy procedure.

07

Results

Posted Dec 12, 2024

Participant flow

Participant flow — Overall Study
MilestoneLevita Magnetic Surgical System
Started30
Completed30
Not completed0

Outcome measures

PrimaryNumber of Tools Required to Retract the Prostate During Procedure

Ability to adequately retract the prostate to achieve an effective exposure of the target tissue. Adequate retraction is achieved if it is not necessary to replace the Levita Magnetic Surgical System with another instrument to retract the prostate during the procedure.

Time frame:
During planned prostatectomy procudure
Reported as:
Number · Additional Tools to Mobilize Liver
Number of Tools Required to Retract the Prostate During Procedure
Additional Tools to Mobilize LiverLevita Magnetic Surgical System
Number of Tools Required to Retract the Prostate During Procedure0
PrimaryIncidence of Device Related Adverse Events (Safety)

All adverse events will be recorded and allocated as to relatedness to device, procedure or other.

Time frame:
Through 30 days post prostatectomy procedure.
Reported as:
Number · Device Related AEs
Incidence of Device Related Adverse Events (Safety)
Device Related AEsLevita Magnetic Surgical System
Incidence of Device Related Adverse Events (Safety)0

Adverse events

Collected over Through 30 days post procedure.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Levita Magnetic Surgical System0/30 (0%)0/30 (0%)10/30 (33.3%)
Most frequent other events
Most frequent other events
EventLevita Magnetic Surgical System
Ecchymosis in Assistant PortSurgical and medical procedures3/30
Abdominal Wall Hematoma in Assistant Port PlacementSurgical and medical procedures2/30
Minor bleeding from surgical site on left flankSurgical and medical procedures1/30
Chest PainGeneral disorders1/30
Meatal StenosisGeneral disorders1/30
Upper Respiratory Tract InfectionRespiratory, thoracic and mediastinal disorders1/30
Ecchymosis Around Surgical Sites and Base of Penis ScrotumSurgical and medical procedures1/30
Infected Pelvic LymphocelesGeneral disorders1/30

Baseline characteristics

Age, Continuous
Age, Continuous(years)Levita Magnetic Surgical System
Mean65 ± 7.3
Sex: Female, Male
Sex: Female, Male(Participants)Levita Magnetic Surgical System
Female0
Male30
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Levita Magnetic Surgical System
Hispanic or Latino30
Not Hispanic or Latino0
Unknown or Not Reported0
Region of Enrollment
Region of Enrollment(participants)Levita Magnetic Surgical System
Chile30
08

Study locations

1 site
  • Fundacion Arturo Lopez Perez (FALP)
    Santiago, Chile
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Oct 12, 2018

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03624465
Lead sponsor
Levita Magnetics
Responsible party
Sponsor
First posted
Aug 10, 2018
Start date
Aug 13, 2018
Primary completion
Mar 25, 2019
Completion
Mar 25, 2019
Results posted
Dec 12, 2024
Last update
Jan 1, 2025

Study contacts

Matthew Gettman, MD
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion